Product Recalls in Connecticut

Product recalls affecting Connecticut — including food, drugs, consumer products, medical devices, and vehicles distributed to Connecticut. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,664 recalls have been distributed to Connecticut in the last 12 months.

51,038 total recalls
2,664 in last 12 months

Showing 901920 of 13,380 recalls

DrugOctober 8, 2024· C & A Naturistics

Recalled Item: AK Forte Ortiga y Omega 3 Cont. Neto 100 Tabletas Recalled by C & A...

The Issue: Marketed without an Approved NDA/ANDA: FDA analysis found the product to be...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 1, 2024· ACCORD HEALTHCARE, INC.

Recalled Item: Cisplatin Injection Recalled by ACCORD HEALTHCARE, INC. Due to Failed...

The Issue: Failed Impurities/Degradation Specifications.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugSeptember 30, 2024· Staska Pharmaceuticals, Inc.

Recalled Item: Ascorbic Acid Inj. Solution Recalled by Staska Pharmaceuticals, Inc. Due to...

The Issue: Presence of Particulate Matter: Presence of glass particulates.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugSeptember 30, 2024· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Ciclopirox Gel 0.77% Recalled by Glenmark Pharmaceuticals Inc., USA Due to...

The Issue: Defective Container: Firm received complaints of broken tube at the seal.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugSeptember 25, 2024· Fresenius Kabi Compounding, LLC

Recalled Item: Thiamine HCl 0.9% Sodium Chloride Injection USP Recalled by Fresenius Kabi...

The Issue: cGMP violations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugSeptember 25, 2024· Fresenius Kabi Compounding, LLC

Recalled Item: Vancomycin HCl 750 mg per 250 mL 0.9% Sodium Chloride Injection USP Recalled...

The Issue: cGMP violations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugSeptember 25, 2024· Fresenius Kabi Compounding, LLC

Recalled Item: NORepinephrine Bitartrate 0.9% Sodium Chloride Injection USP Recalled by...

The Issue: cGMP violations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugSeptember 25, 2024· Fresenius Kabi Compounding, LLC

Recalled Item: NORepinephrine Bitartrate 0.9% Sodium Chloride Injection USP Recalled by...

The Issue: cGMP violations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugSeptember 25, 2024· Fresenius Kabi Compounding, LLC

Recalled Item: Phenylephrine HCl 0.9% Sodium Chloride Injection USP Recalled by Fresenius...

The Issue: cGMP violations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugSeptember 25, 2024· Fresenius Kabi Compounding, LLC

Recalled Item: EPINEPHrine 0.9% Sodium Chloride Injection USP Recalled by Fresenius Kabi...

The Issue: cGMP violations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugSeptember 25, 2024· Fresenius Kabi Compounding, LLC

Recalled Item: Oxytocin 0.9% Sodium Chloride Injection USP Recalled by Fresenius Kabi...

The Issue: cGMP violations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugSeptember 25, 2024· Fresenius Kabi Compounding, LLC

Recalled Item: Phenylephrine HCl 0.9% Sodium Chloride Injection USP Recalled by Fresenius...

The Issue: cGMP violations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugSeptember 25, 2024· Fresenius Kabi Compounding, LLC

Recalled Item: Phenylephrine HCl 0.9% Sodium Chloride Injection USP Recalled by Fresenius...

The Issue: CGMP violations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugSeptember 25, 2024· Fresenius Kabi Compounding, LLC

Recalled Item: Phenylephrine HCl 0.9% Sodium Chloride Injection USP Recalled by Fresenius...

The Issue: cGMP violations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugSeptember 24, 2024· Nivagen Pharmaceuticals Inc

Recalled Item: Atorvastatin Calcium Tablets Recalled by Nivagen Pharmaceuticals Inc Due to...

The Issue: Presence of Foreign Tablets/Capsules: A Carbamazepine Extended-Release 400...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugSeptember 24, 2024· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Ryaltris (olopatadine hydrochloride and mometasone fluorate) Nasal Spray...

The Issue: Defective Delivery System: The dip tube is clogged causing the spray not to...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugSeptember 19, 2024· Gilead Sciences, Inc.

Recalled Item: Veklury (remdesivir) for injection Recalled by Gilead Sciences, Inc. Due to...

The Issue: Presence of Particulate Matter: Presence of glass particle.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugSeptember 17, 2024· Bionpharma Inc.

Recalled Item: Atovaquone Oral Suspension Recalled by Bionpharma Inc. Due to Microbial...

The Issue: Microbial Contamination of a Non-sterile Product: The product was found to...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugSeptember 16, 2024· AbbVie Inc.

Recalled Item: P.M. Recalled by AbbVie Inc. Due to Lack of Assurance of Sterility: The...

The Issue: Lack of Assurance of Sterility: The impacted lots may contain a breach in...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugSeptember 16, 2024· AbbVie Inc.

Recalled Item: LACRI-LUBE Recalled by AbbVie Inc. Due to Lack of Assurance of Sterility:...

The Issue: Lack of Assurance of Sterility: The impacted lots may contain a breach in...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund